Arcturus Therapeutics Holdings Inc. (ARCT) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 610K | 3.08M | 17.15M | 24.51M | 29.38M | 21M | 38.81M | 45.98M | 32.6M | 25.08M | 43.38M | 10.52M |
| Revenue Growth % | -97.92% | -85.33% | -55.81% | -46.69% | -9.87% | -16.26% | -10.51% | 337.08% | -59.4% | -84.35% | 224.45% | -61.17% |
| Cost of Goods Sold | 658K | 0 | 3.34M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.74M |
| COGS % of Revenue | 107.87% | - | 19.49% | - | - | - | - | - | - | - | - | 35.56% |
| Gross Profit | -48K | 3.08M | 13.81M | 24.51M | 29.38M | 21M | 38.81M | 45.98M | 32.6M | 25.08M | 43.38M | 6.78M |
| Gross Margin % | -7.87% | 100% | 80.51% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 64.44% |
| Gross Profit Growth % | -100.16% | -85.33% | -64.42% | -46.69% | -9.87% | -16.26% | -10.51% | 578.31% | 14.31% | -81.19% | 278.36% | 161.09% |
| Operating Expenses | 29.73M | 34.39M | 30.32M | 36.13M | 46.21M | 54.39M | 49.55M | 67.1M | 63.01M | 43.35M | 62.69M | 62.15M |
| OpEx % of Revenue | 4874.1% | 1116.13% | 176.79% | 147.39% | 157.27% | 259.02% | 127.66% | 145.95% | 193.29% | 172.86% | 144.53% | 590.85% |
| Selling, General & Admin | 8.81M | 14.03M | 10.4M | 10.34M | 11.31M | 12.38M | 13.28M | 12.32M | 14.85M | 12.51M | 13.38M | 13.22M |
| SG&A % of Revenue | 1443.77% | 455.27% | 60.63% | 42.18% | 38.51% | 58.95% | 34.2% | 26.79% | 45.56% | 49.87% | 30.84% | 125.72% |
| Research & Development | 20.93M | 24.48M | 23.27M | 29.58M | 34.89M | 43.78M | 39.13M | 58.67M | 53.57M | 36.62M | 51.08M | 52.67M |
| R&D % of Revenue | 3430.33% | 794.42% | 135.65% | 120.68% | 118.76% | 208.48% | 100.82% | 127.61% | 164.34% | 146.02% | 117.75% | 500.69% |
| Other Operating Expenses | 0 | -1000K | -1000K | -1000K | 0 | -1000K | -1000K | -1000K | -1000K | -1000K | -1000K | -1000K |
| Operating Income | -29.78M | -31.31M | -16.51M | -11.62M | -16.83M | -33.39M | -10.74M | -21.13M | -30.41M | -18.27M | -19.31M | -55.37M |
| Operating Margin % | -4881.97% | -1016.13% | -96.27% | -47.39% | -57.27% | -159.02% | -27.66% | -45.95% | -93.29% | -72.86% | -44.53% | -526.42% |
| Operating Income Growth % | -76.99% | 6.25% | -53.79% | 45.02% | 44.67% | -82.76% | 44.41% | 61.85% | -306.11% | -115.04% | 47.53% | -150.69% |
| EBITDA | -29.12M | -30.63M | -15.75M | -10.84M | -16.02M | -32.58M | -9.82M | -20.22M | -29.51M | -17.46M | -18.49M | -54.64M |
| EBITDA Margin % | -4774.1% | -994% | -91.83% | -44.21% | -54.54% | -155.12% | -25.31% | -43.97% | -90.52% | -69.61% | -42.62% | -519.41% |
| EBITDA Growth % | -81.73% | 5.99% | -60.3% | 46.4% | 45.69% | -86.6% | 46.85% | 63% | -292.45% | -114.31% | 49.2% | -151.16% |
| D&A (Non-Cash Add-back) | 658K | 682K | 763K | 779K | 801K | 819K | 912K | 909K | 904K | 815K | 827K | 737K |
| EBIT | -29.78M | -20.82M | -13.45M | -11.62M | -16.83M | -30.01M | -7.12M | -21.13M | -30.41M | -11.44M | -19.31M | -55.37M |
| Net Interest Income | 1.93M | 1.53M | 3.23M | 2.57M | 2.77M | 3.21M | 7.64M | 4.15M | 4.02M | 6.88M | 3.98M | 3.25M |
| Interest Income | 1.93M | 1.53M | 3.23M | 2.57M | 2.77M | 3.21M | 7.64M | 4.15M | 4.02M | 6.89M | 4M | 3.25M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4K | 20K | 0 |
| Other Income/Expense | 2.82M | 2.22M | 3.06M | 2.44M | 2.75M | 3.38M | 3.62M | 3.76M | 3.96M | 6.83M | 3.98M | 3.4M |
| Pretax Income | -26.96M | -29.08M | -13.45M | -9.18M | -14.08M | -30.01M | -7.12M | -17.37M | -26.45M | -11.45M | -15.33M | -51.97M |
| Pretax Margin % | -4420.33% | -943.95% | -78.41% | -37.44% | -47.91% | -142.9% | -18.34% | -37.77% | -81.14% | -45.64% | -35.34% | -494.09% |
| Income Tax | 0 | -4K | 0 | 4K | 0 | -4K | -217K | -150K | 368K | 262K | 893K | 577K |
| Effective Tax Rate % | 0% | 0.01% | 0% | -0.04% | 0% | 0.01% | 3.05% | 0.86% | -1.39% | -2.29% | -5.83% | -1.11% |
| Net Income | -26.96M | -29.08M | -13.45M | -9.18M | -14.08M | -30M | -6.9M | -17.22M | -26.82M | -11.71M | -16.22M | -52.55M |
| Net Margin % | -4420.33% | -943.82% | -78.41% | -37.45% | -47.91% | -142.88% | -17.78% | -37.45% | -82.27% | -46.68% | -37.4% | -499.57% |
| Net Income Growth % | -91.56% | 3.09% | -94.81% | 46.68% | 47.51% | -156.3% | 57.45% | 67.24% | -152.84% | -109.98% | 54% | -143.7% |
| Net Income (Continuing) | -26.96M | -29.08M | -13.45M | -9.18M | -14.08M | -30M | -6.9M | -17.22M | -26.82M | -11.71M | -16.22M | -52.55M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.95 | -1.05 | -0.49 | -0.34 | -0.52 | -1.11 | -0.26 | -0.64 | -1.00 | -0.32 | -0.61 | -1.98 |
| EPS Growth % | -82.69% | 5.41% | -88.46% | 46.88% | 48% | -246.88% | 57.38% | 67.68% | -153.48% | -107.39% | 53.08% | -141.46% |
| EPS (Basic) | -0.95 | -1.05 | -0.49 | -0.34 | -0.52 | -1.11 | -0.26 | -0.64 | -1.00 | -0.32 | -0.61 | -1.98 |
| Diluted Shares Outstanding | 28.42M | 27.39M | 27.19M | 27.13M | 27.11M | 27M | 27.06M | 26.97M | 26.88M | 26.63M | 26.57M | 26.56M |
| Basic Shares Outstanding | 28.42M | 27.39M | 27.19M | 27.13M | 27.11M | 27M | 27.06M | 26.97M | 26.88M | 26.63M | 26.57M | 26.56M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |